|
Summary Information: Denali Therapeutics Inc. Common Stock NASDAQ:DNLI |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases. Denali pursues new treatments by rigorously assessing genetically validated targets, engineering delivery across the BBB and guiding development through biomarkers that demonstrate target and pathway engagement. Denali is based in South San Francisco.
__The following are links to various summary and news pages for __Denali Therapeutics Inc. Common Stock [ DNLI ]. __Note: Some Links might not have information for the company. |
|